Inventor · disambiguated record
Rachael C. Hunter
Also filed as: HUNTER RACHAEL · HUNTER RACHAEL C · HUNTER RACHAEL CATHERINE
13 granted patents·102 citations·filing 2002–2012
91Inventor score
Top patents by PatentIndex Score
13 records- 0195US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0288US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 0386US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 0485US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 0585US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 0684US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 0777US8242112B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2011·Granted Aug 14, 2012·2 cites·4 claims
- 0877US6887889B2Aryl and biaryl piperdines with MCH modulatory activityPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted May 3, 2005·11 cites·27 claims
- 0974US8178513B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2009·Granted May 15, 2012·1 cites·13 claims
- 1073US8471005B2Pyrrolotriazines as ALK and JAK2 inhibitorsBRESLIN HENRY J·Filed 2011·Granted Jun 25, 2013·3 cites·10 claims
- 1162US7034056B2Aryl and biaryl compounds having MCH modulatory activityPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Apr 25, 2006·1 cites·26 claims
- 1261US8778980B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Jul 15, 2014·0 cites·15 claims
- 1346US7511146B22-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted Mar 31, 2009·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →